127 related articles for article (PubMed ID: 12580032)
1. [Serum soluble interleukin-2 receptor levels in uveitis].
Xie C; Huang X; Zhou H; Yang P
Yan Ke Xue Bao; 1998 Jun; 14(2):64-5. PubMed ID: 12580032
[TBL] [Abstract][Full Text] [Related]
2. Soluble intercellular adhesion molecule-1 (ICAM-1), CD4, CD8 and interleukin-2 receptor in patients with Behçet's disease and Vogt-Koyanagi-Harada's disease.
Uchio E; Matsumoto T; Tanaka SI; Ohno S
Clin Exp Rheumatol; 1999; 17(2):179-84. PubMed ID: 10342043
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Value of Serum-Soluble Interleukin 2 Receptor Levels vs Angiotensin-Converting Enzyme in Patients With Sarcoidosis-Associated Uveitis.
Groen-Hakan F; Eurelings L; ten Berge JC; van Laar J; Ramakers CRB; Dik WA; Rothova A
JAMA Ophthalmol; 2017 Dec; 135(12):1352-1358. PubMed ID: 29121154
[TBL] [Abstract][Full Text] [Related]
4. Levels of soluble ICAM-1 and soluble IL-2R in the serum and aqueous humor of uveitis patients.
Martin CM; Lacomba MS; Molina CI; Chamond RR; Galera JM; Estevez EC
Curr Eye Res; 2000 Apr; 20(4):287-92. PubMed ID: 10806443
[TBL] [Abstract][Full Text] [Related]
5. Serum interleukin 2-receptor levels in uveitis.
Arocker-Mettinger E; Asenbauer T; Ulbrich S; Grabner G
Curr Eye Res; 1990; 9 Suppl():25-9. PubMed ID: 2384010
[TBL] [Abstract][Full Text] [Related]
6. Type III procollagen N-terminal propeptide, soluble interleukin-2 receptor, and von Willebrand factor in systemic sclerosis.
Lee YJ; Shin KC; Kang SW; Lee EB; Kim HA; Song YW
Clin Exp Rheumatol; 2001; 19(1):69-74. PubMed ID: 11247328
[TBL] [Abstract][Full Text] [Related]
7. [Effects of hyperbaric oxygen therapy on the changes in serum sIL-2R and Fn in severe burn patients].
Xu N; Li Z; Luo X
Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1999 May; 15(3):220-3. PubMed ID: 11501128
[TBL] [Abstract][Full Text] [Related]
8. Serum soluble interleukin-2 receptor levels do not correlate with an associated systemic disease in patients with uveitis.
Papadaki T; Iaccheri B; Fiore T; Zacharopoulos I; Thadani S; Christen W; Androudi S; Foster CS
Acta Ophthalmol; 2010 Mar; 88(2):e28-9. PubMed ID: 19493254
[No Abstract] [Full Text] [Related]
9. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B
Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of soluble interleukin-2 receptor in patients with ANCA-associated vasculitis.
Arranz O; Ara J; Rodríguez R; Saurina A; Mirapeix E; Darnell A
J Nephrol; 2000; 13(1):59-64. PubMed ID: 10720216
[TBL] [Abstract][Full Text] [Related]
11. In vivo production of type 1 cytokines in healthy sickle cell disease patients.
Taylor SC; Shacks SJ; Qu Z
J Natl Med Assoc; 1999 Nov; 91(11):619-24. PubMed ID: 10641497
[TBL] [Abstract][Full Text] [Related]
12. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
[TBL] [Abstract][Full Text] [Related]
13. Serum evaluation of the balance between soluble interleukin-2 and interleukin-4 receptors.
Fujita N; Okamoto Y; Gotoh Y; Yada Y; Suzuki Y; Ando T; Togari H; Nishida M
Cytokine; 2005 Nov; 32(3-4):143-8. PubMed ID: 16226465
[TBL] [Abstract][Full Text] [Related]
14. Levels of soluble interleukin-2 receptor in the sera and skin tissue fluids of patients with vitiligo.
Caixia T; Hongwen F; Xiran L
J Dermatol Sci; 1999 Sep; 21(1):59-62. PubMed ID: 10468193
[TBL] [Abstract][Full Text] [Related]
15. Changes in the levels of serum-soluble interleukin-2 receptor after surgical stress.
Murakami S; Sakata H; Tsuji Y; Okubo K; Takahashi T; Kikuchi M; Hirayama R
Surg Today; 2003; 33(8):565-70. PubMed ID: 12884092
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-2 receptor levels in sera of patients with rheumatoid arthritis treated with sulfasalazine, parenteral gold, or placebo.
Merkel PA; Dooley MA; Dawson DV; Pisetsky DS; Polisson RP
J Rheumatol; 1996 Nov; 23(11):1856-61. PubMed ID: 8923356
[TBL] [Abstract][Full Text] [Related]
17. The levels of plasma interleukin-2 and soluble interleukin-2R in Behçet's disease: a marker of disease activity.
Alpsoy E; Cayirli C; Er H; Yilmaz E
J Dermatol; 1998 Aug; 25(8):513-6. PubMed ID: 9769596
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum interleukin 1 receptors and interleukin 1B in patients with Behçet's disease: correlations with disease activity and severity.
Yosipovitch G; Shohat B; Bshara J; Wysenbeek A; Weinberger A
Isr J Med Sci; 1995 Jun; 31(6):345-8. PubMed ID: 7607852
[TBL] [Abstract][Full Text] [Related]
19. Aspirin reduces serum anti-melanocyte antibodies and soluble interleukin-2 receptors in vitiligo patients.
Zailaie MZ
Saudi Med J; 2005 Jul; 26(7):1085-91. PubMed ID: 16047057
[TBL] [Abstract][Full Text] [Related]
20. The roles of serum IL-18, IL-10, TNF-alpha and sIL-2R in patients with chronic hepatitis C.
Jia HY; Du J; Zhu SH; Ma YJ; Chen HY; Yang BS; Cai HF
Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):378-82. PubMed ID: 14607710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]